PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsessential hypertension
MeSH D000075222 - essential hypertension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006973:Hypertension
244 Companies
95 Drugs
$
Success rate
D000075222: 
Essential hypertension
2 Companies
3 Drugs
$
Success rate
D000092244:Isolated systolic hypertension
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganTelmisartan, Hydrochlorothiazide Actelsar  2013-03-13   
Nova LaboratoriesSpironolactone Qaialdo  2023-05-26   
Clinical Trials
Historical Success Rate
Phase 1
62%
16/26
Phase 2
66%
19/29
Phase 3
71%
20/28
Approved: 1Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Hydrochlorothiazide
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use